Total Payments
$3,676
2024 Payments
$867.43
Companies
28
Transactions
186
Medicare Patients
4,100
Medicare Billing
$373,602
Payment Breakdown by Category
Food & Beverage$3,604 (98.0%)
Education$72.00 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,604 | 185 | 98.0% |
| Education | $72.00 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $711.53 | 38 | $0 (2024) |
| ABBVIE INC. | $653.67 | 33 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $245.43 | 12 | $0 (2024) |
| LEO Pharma Inc. | $211.40 | 8 | $0 (2019) |
| Allergan Inc. | $179.04 | 12 | $0 (2019) |
| Celgene Corporation | $150.87 | 5 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $149.02 | 7 | $0 (2024) |
| Amgen Inc. | $141.86 | 7 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $114.26 | 9 | $0 (2017) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $112.51 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $867.43 | 40 | Janssen Biotech, Inc. ($351.07) |
| 2023 | $694.95 | 35 | ABBVIE INC. ($159.57) |
| 2020 | $31.30 | 2 | AbbVie Inc. ($18.37) |
| 2019 | $432.00 | 20 | AbbVie, Inc. ($61.88) |
| 2018 | $668.71 | 33 | Novartis Pharmaceuticals Corporation ($127.10) |
| 2017 | $981.64 | 56 | AbbVie, Inc. ($152.47) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Immunology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.30 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: Immunology | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Solta Medical, a division of Bausch Health US, LLC | Fraxel, Clear & Brilliant | Food and Beverage | In-kind items and services | $20.90 | General |
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Immunology | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.27 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,176 | 1,672 | $331,057 | $115,529 |
| 2022 | 14 | 1,075 | 1,561 | $285,296 | $100,517 |
| 2021 | 11 | 984 | 1,366 | $246,625 | $89,147 |
| 2020 | 13 | 865 | 1,150 | $219,935 | $68,409 |
Total Patients
4,100
Total Services
5,749
Medicare Billing
$373,602
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 433 | 652 | $127,140 | $49,925 | 39.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 165 | $41,250 | $14,921 | 36.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 195 | 225 | $43,650 | $11,436 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 96 | $25,536 | $10,569 | 41.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $19,494 | $7,202 | 36.9% |
| 13120 | Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | Office | 2023 | 13 | 16 | $13,776 | $5,346 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $15,045 | $4,297 | 28.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 37 | $11,100 | $3,630 | 32.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 15 | 17 | $11,594 | $2,114 | 18.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 131 | 284 | $6,248 | $1,696 | 27.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 29 | $3,625 | $1,383 | 38.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $6,567 | $1,157 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 23 | $2,576 | $1,100 | 42.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 16 | $2,240 | $728.35 | 32.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 32 | $1,216 | $26.76 | 2.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 430 | 624 | $121,680 | $47,374 | 38.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 117 | 136 | $34,000 | $12,358 | 36.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 164 | 202 | $39,188 | $9,835 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 75 | $19,950 | $7,916 | 39.7% |
| 13120 | Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | Office | 2022 | 13 | 15 | $12,915 | $5,089 | 39.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 40 | 42 | $12,600 | $4,050 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $10,620 | $3,541 | 33.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 14 | 17 | $7,055 | $2,270 | 32.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 38 | $4,750 | $1,909 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 34 | $3,808 | $1,791 | 47.0% |
About Dr. William Long, MD
Dr. William Long, MD is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497708168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Long, MD has received a total of $3,676 in payments from pharmaceutical and medical device companies, with $867.43 received in 2024. These payments were reported across 186 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,604).
As a Medicare-enrolled provider, Long has provided services to 4,100 Medicare beneficiaries, totaling 5,749 services with total Medicare billing of $373,602. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 05/17/2006
- Last Updated 01/17/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497708168
Products in Payments
- TREMFYA (Drug) $413.87
- Humira (Biological) $264.60
- Otezla (Drug) $202.61
- COSENTYX (Biological) $196.69
- Tremfya (Drug) $177.89
- SKYRIZI (Biological) $176.28
- ENSTILAR (Drug) $166.03
- Sotyktu (Drug) $149.02
- RINVOQ (Biological) $133.53
- VTAMA (Drug) $93.15
- OPZELURA (Drug) $91.76
- ONEXTON (Drug) $84.08
- Finacea (Drug) $83.97
- DUPIXENT (Biological) $72.43
- EUCRISA (Drug) $70.76
- STELARA (Biological) $64.46
- DUPIXENT DUPILUMAB INJECTION (Biological) $63.06
- Seysara (Drug) $62.10
- DUOBRII (Drug) $56.90
- REMICADE (Biological) $55.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M